Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_assertion type Assertion NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_head.
- NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_assertion description "[Previous studies have showed that miR-100 is downregulated in human prostate cancer tissue compared to normal prostate and also significantly decreased in bone metastatic prostate cancer samples compared with primary prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_provenance.
- NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_assertion evidence source_evidence_literature NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_provenance.
- NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_assertion SIO_000772 24805183 NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_provenance.
- NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_assertion wasDerivedFrom befree-2016 NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_provenance.
- NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_assertion wasGeneratedBy ECO_0000203 NP1180235.RALjn1l15U5S_XAAB26rIp0isZholTcfMWIKctBvr8zd0130_provenance.